PLN 9.19M, including 10% contingency
PLN 4.46M · about PLN 355k per month
PLN 4.73M · about PLN 389k per month
First institutional income expected from H2 2028
All amounts are the full cost to the company: gross pay plus employer contributions, excluding VAT. The main study is not in this budget: it is funded by an external sponsor. The following pages show each cost line, the team, research and how the round is staged.
| Category | What it covers | 24 months (PLN) | USD | Share |
|---|---|---|---|---|
| Team | IT (3), education (2), CEO, communication, assistant, indexation | 3,432,000 | $920k | 41% |
| US go-to-market | Advisory Circle, Operations Lead, US employment costs | 1,920,000 | $515k | 23% |
| Market | Travel, fairs and conferences, App Store reach | 1,240,000 | $332k | 15% |
| Research (direct) | Feasibility study and research support; full programme on the next page | 600,000 | $161k | 7% |
| Operations | Accounting, administration, Warsaw office | 480,000 | $129k | 6% |
| Legal & compliance | US entity, contracts, regulatory opinion, insurance | 400,000 | $107k | 5% |
| Product | Pilot hardware, cloud and AI compute, equipment | 280,000 | $75k | 3% |
| Subtotal | 8,352,000 | $2.24M | 100% | |
| Contingency | 10% of all costs | 835,200 | $224k | |
| Total | 9,187,200 | $2.46M |
| Budget line | Research work in this line | Line (PLN) | Share | Research (PLN) |
|---|---|---|---|---|
| Research (direct) | Feasibility study, research support and analysis | 600,000 | 100% | 600,000 |
| IT team | Adapting Glaze to study protocols and data needs | 1,680,000 | 40% | 672,000 |
| Education team | Study materials, session guides, staff training | 960,000 | 50% | 480,000 |
| US Advisory Circle | Access to study sites and clinical partners | 720,000 | 100% | 720,000 |
| US Operations Lead | Recruiting and running research partner sites | 1,200,000 | 30% | 360,000 |
| Legal & compliance | Study agreements, data terms, study insurance | 400,000 | 50% | 200,000 |
| Research programme | 36% of costs before contingency (PLN 8.35M) | 3,032,000 |
$813k over 24 months. Shares are management estimates of time spent on research work; IT 40% set by the CEO, other shares to be confirmed. US Operations Lead includes US employment costs.
| Role | People | PLN / month | Months |
|---|---|---|---|
| IT team — engineering | Marcin Gorzyński (lead), Bartosz Maciurak, Janusz Bosy; not full time | 70,000 | 1–24 |
| Education & institutional communication | Julia Konieczna, Zofia Czartoryska | 40,000 | 1–24 |
| CEO | Robert Latos | 20,000 | 1–24 |
| Assistant | To be named | 10,000 | 1–24 |
| US Advisory Circle | Retired hospital administrators; retainer plus equity | 30,000 | 1–24 |
| US Institutional Operations Lead | To be hired; leads institutions through the process | 30,000 → 50,000 | 1–12 → 13–24 |
Not on the payroll: Marcin Molski, co-founder, supports the company while working full time for a production company in San Francisco. Year 2 adds 5% indexation on IT, education and assistant; US employment costs add 25% on the Operations Lead.
Feasibility study, funded by Well of Art, with results around month 9. The research programme as a whole, including team time on study work, is PLN 3.03M ($813k), 36% of costs.
The main study. Planned to start in H2 2027 and finish by the end of 2028. It needs an external sponsor, still to be secured.
The main study is designed to be independent of the company: an external sponsor and an independent research partner keep the result credible to hospitals and funders.
PLN 4.46M · raised now
PLN 4.73M · raised on feasibility results
Feasibility results.
Stage 2 raised on the results. Three months of runway as buffer.
Year 2: US operations at full cost, second batch of pilot hardware.